HI
DTIL icon

Harbour Investments’s Precision BioSciences DTIL Stock Holding History

Harbour Investments’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24 Hold
3
– – ﹤0.01% 4716
2026
Q1 		$17 Hold
3
– – ﹤0.01% 4629
2025
Q4 		$12 Hold
3
– – ﹤0.01% 3838
2025
Q3 		$17 Hold
3
– – ﹤0.01% 3715
2025
Q2 		$13 Hold
3
– – ﹤0.01% 3584
2025
Q1 		$14 Hold
3
– – ﹤0.01% 3528
2024
Q4 		$11 Hold
3
– – ﹤0.01% 3468
2024
Q3 		$27 Hold
3
– – ﹤0.01% 3362
2024
Q2 		$29 Buy
+3
New +$35 ﹤0.01% 3254

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Harbour Investments's DTIL Position: Q2 2026 in Review

Harbour Investments held its Precision BioSciences (DTIL) position steady in Q2 2026 at 3 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #4716.

Harbour Investments first reported a position in DTIL in Q2 2024 and has held it in 9 quarters since. The position peaked at $29 in Q2 2024. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Harbour Investments held 3 shares of Precision BioSciences worth $24 as of Q2 2026.
  • Harbour Investments left its Precision BioSciences share count unchanged in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4716 holding.
  • Harbour Investments first reported a position in Precision BioSciences in Q2 2024 and has held it in 9 quarters since.
  • Harbour Investments's Precision BioSciences position peaked at $29 in Q2 2024.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.